Biocryst Pharma Inc (BCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 274,348 | 115,723 | 28,275 | 53,568 | 23,650 |
| Marketable Securities | 28,239 | 22,054 | 77,736 | 64,115 | 32,546 |
| Receivables | 8,646 | 22,146 | 4,293 | 6,117 | 8,768 |
| Inventories | 7,039 | N/A | 1,649 | N/A | 500 |
| Other current assets | 0 | 0 | 0 | 210 | 85 |
| TOTAL | $323,800 | $164,345 | $114,352 | $125,391 | $66,987 |
| Non-Current Assets | |||||
| PPE Net | 7,113 | 7,347 | 9,135 | 9,546 | 9,922 |
| Investments And Advances | 0 | 0 | 22,376 | 41,295 | 8,926 |
| Other Non-Current Assets | 3,802 | 3,590 | 978 | 2,027 | 4,012 |
| TOTAL | $10,915 | $10,937 | $32,489 | $52,868 | $22,860 |
| Total Assets | $334,715 | $175,282 | $146,841 | $178,259 | $89,847 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 9,020 | 4,580 | 6,464 | N/A |
| Accounts payable and accrued liabilities | 40,383 | 28,892 | 19,617 | 18,432 | 13,259 |
| Accrued Expenses | 33,942 | 21,365 | 15,891 | 12,699 | 10,836 |
| TOTAL | $105,654 | $92,335 | $69,477 | $74,836 | $54,360 |
| Non-Current Liabilities | |||||
| Long Term Debt | 244,452 | 41,289 | 25,372 | 16,750 | 22,777 |
| Deferred Revenues | 150 | 2,120 | 221 | 8,484 | 2,022 |
| TOTAL | $248,323 | $44,695 | $28,129 | $19,656 | $33,909 |
| Total Liabilities | $353,977 | $137,030 | $97,606 | $94,492 | $88,269 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 177,183 | 154,192 | 110,177 | 98,606 | 73,955 |
| Common Shares | 1,769 | 1,541 | 1,101 | 984 | 738 |
| Retained earnings | -1,023,442 | -840,628 | -731,969 | -631,843 | -566,061 |
| Other shareholders' equity | 3 | 39 | -297 | -243 | -12 |
| TOTAL | $-19,262 | $38,252 | $49,235 | $83,767 | $1,578 |
| Total Liabilities And Equity | $334,715 | $175,282 | $146,841 | $178,259 | $89,847 |